摘要
心房颤动(AF)合并慢性肾脏病(CKD)的患者越来越多,患者相对更容易发生血栓栓塞或出血。随着直接口服抗凝剂(DOAC)的逐渐应用,临床医生及患者有了更多的选择。除抗凝治疗外,非抗凝药物治疗及中医药治疗也逐渐进入临床。文章就心房颤动合并慢性肾脏病的相关临床研究进展进行综述。
There are more and more patients with atrial fibrillation(AF)combined with chronic kidney disease(CKD),and patients are relatively more prone to thromboembolism or bleeding.With the gradual application of direct oral anticoagulants(DOAC),clinicians and patients have more choices.In addition to anticoagulant therapy,non-anticoagulant drug therapy and traditional Chinese medicine therapy have gradually entered the clinic.This article reviews the progress of clinical research on atrial fibrillation combined with chronic kidney disease.
作者
吴毅(综述)
何艳(审校)
Wu Yi;He Yan(Department of Cardiology, Affiliated Hospital, Guizhou Medical University, Guizhou Province,Guiyang 550001, China)
出处
《疑难病杂志》
CAS
2021年第7期726-730,735,共6页
Chinese Journal of Difficult and Complicated Cases
关键词
心房颤动
肾脏病
慢性
抗凝治疗
非抗凝药物治疗
中医药治疗
Atrial fibrillation
Kidney disease,chronic
Anticoagulant therapy
Non-anticoagulant therapy
Traditional Chinese medicine therapy
